These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 34169445)

  • 1. Chlorhexidine leads to the evolution of antibiotic-resistant Pseudomonas aeruginosa.
    Tag ElDein MA; Yassin AS; El-Tayeb O; Kashef MT
    Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2349-2361. PubMed ID: 34169445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran.
    Goli HR; Nahaei MR; Rezaee MA; Hasani A; Samadi Kafil H; Aghazadeh M; Sheikhalizadeh V
    Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation-driven β-lactam resistance mechanisms among contemporary ceftazidime-nonsusceptible Pseudomonas aeruginosa isolates from U.S. hospitals.
    Castanheira M; Mills JC; Farrell DJ; Jones RN
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6844-50. PubMed ID: 25182652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
    Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A
    PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
    Pan YP; Xu YH; Wang ZX; Fang YP; Shen JL
    Arch Microbiol; 2016 Aug; 198(6):565-71. PubMed ID: 27060003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa.
    Goli HR; Nahaei MR; Rezaee MA; Hasani A; Kafil HS; Aghazadeh M; Nikbakht M; Khalili Y
    J Infect Public Health; 2018; 11(3):364-372. PubMed ID: 28993173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the MexEF-OprN efflux system in low-level resistance of Pseudomonas aeruginosa to ciprofloxacin.
    Llanes C; Köhler T; Patry I; Dehecq B; van Delden C; Plésiat P
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5676-84. PubMed ID: 21911574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis.
    Chalhoub H; Sáenz Y; Nichols WW; Tulkens PM; Van Bambeke F
    Int J Antimicrob Agents; 2018 Nov; 52(5):697-701. PubMed ID: 30081137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.
    Dean CR; Visalli MA; Projan SJ; Sum PE; Bradford PA
    Antimicrob Agents Chemother; 2003 Mar; 47(3):972-8. PubMed ID: 12604529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meropenem potentiation of aminoglycoside activity against Pseudomonas aeruginosa: involvement of the MexXY-OprM multidrug efflux system.
    Poole K; Gilmour C; Farha MA; Parkins MD; Klinoski R; Brown ED
    J Antimicrob Chemother; 2018 May; 73(5):1247-1255. PubMed ID: 29420743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Compensation of Fitness Costs Is a General Outcome for Antibiotic-Resistant
    Olivares Pacheco J; Alvarez-Ortega C; Alcalde Rico M; Martínez JL
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assignment of the substrate-selective subunits of the MexEF-OprN multidrug efflux pump of Pseudomonas aeruginosa.
    Maseda H; Yoneyama H; Nakae T
    Antimicrob Agents Chemother; 2000 Mar; 44(3):658-64. PubMed ID: 10681335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fmt bypass in Pseudomonas aeruginosa causes induction of MexXY efflux pump expression.
    Caughlan RE; Sriram S; Daigle DM; Woods AL; Buco J; Peterson RL; Dzink-Fox J; Walker S; Dean CR
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5015-21. PubMed ID: 19786597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Vettoretti L; Plésiat P; Muller C; El Garch F; Phan G; Attrée I; Ducruix A; Llanes C
    Antimicrob Agents Chemother; 2009 May; 53(5):1987-97. PubMed ID: 19258280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa.
    Islam S; Jalal S; Wretlind B
    Clin Microbiol Infect; 2004 Oct; 10(10):877-83. PubMed ID: 15373880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Ciprofloxacin Concentrations Select Multidrug-Resistant Mutants Overproducing Efflux Pumps in Clinical Isolates of Pseudomonas aeruginosa.
    Sanz-García F; Hernando-Amado S; López-Causapé C; Oliver A; Martínez JL
    Microbiol Spectr; 2022 Oct; 10(5):e0072322. PubMed ID: 36000896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.
    Adamson DH; Krikstopaityte V; Coote PJ
    J Antimicrob Chemother; 2015 Aug; 70(8):2271-8. PubMed ID: 25921513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin.
    Puja H; Bolard A; Noguès A; Plésiat P; Jeannot K
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spread of efflux pump-overexpressing, non-metallo-beta-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity.
    Pournaras S; Maniati M; Spanakis N; Ikonomidis A; Tassios PT; Tsakris A; Legakis NJ; Maniatis AN
    J Antimicrob Chemother; 2005 Oct; 56(4):761-4. PubMed ID: 16115825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa.
    Baum EZ; Crespo-Carbone SM; Morrow BJ; Davies TA; Foleno BD; He W; Queenan AM; Bush K
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2785-90. PubMed ID: 19433554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.